What Therapeutic Drugs should be Monitored?
- 1 August 1985
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 326 (8450) , 309-310
- https://doi.org/10.1016/s0140-6736(85)90354-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Therapeutic Drug Monitoring—the Need for Audit?Scottish Medical Journal, 1985
- Plasma concentrations and therapeutic effect of anti-inflammatory and anti-rheumatic drugsPharmacology & Therapeutics, 1982
- Serum phenytoin concentration and clinical response in patients with epilepsy.Published by Wiley ,1981
- Phenytoin Monotherapy for Epilepsy: A Long‐Term Prospective Study, Assisted by Serum Level Monitoring, in Previously Untreated PatientsEpilepsia, 1981
- Therapeutic Monitoring of Valproic AcidTherapeutic Drug Monitoring, 1980
- Clinical Pharmacokinetics of ProcainamideClinical Pharmacokinetics, 1978
- Plasma levels and antidepressive effect of imipramineClinical Pharmacology & Therapeutics, 1976
- Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple dosesEuropean Journal of Clinical Pharmacology, 1975
- Anticonvulsant Effect of Diphenylhydantoin Relative to Plasma LevelsArchives of Neurology, 1974
- Relationship between Plasma Level and Therapeutic Effect of NortriptylineBMJ, 1971